These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 49293)
21. Chemotactic deactivation of human neutrophils: role of stimulation of hexose monophosphate shunt activity in nonspecific deactivation. Nelson RD; Fiegel VD; Herron MJ; Gracyk JM; Bauman MP; McCormack RT; Simmons RL Acta Physiol Scand Suppl; 1980; 492():31-41. PubMed ID: 6784446 [TBL] [Abstract][Full Text] [Related]
22. Migration of neutrophils across endothelial monolayers is stimulated by treatment of the monolayers with interleukin-1 or tumor necrosis factor-alpha. Furie MB; McHugh DD J Immunol; 1989 Nov; 143(10):3309-17. PubMed ID: 2553810 [TBL] [Abstract][Full Text] [Related]
23. The main serum protease inhibitors; alpha-1-proteinase inhibitor and alpha-2-macroglobulin inhibit H2O2 release from human polymorphonuclear leukocytes stimulated with phorbol myristate acetate. Nowak D; Piasecka G Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):51-60. PubMed ID: 1725105 [TBL] [Abstract][Full Text] [Related]
24. Modulation of human neutrophilic granulocyte functions by recombinant human tumor necrosis factor and recombinant human lymphotoxin. Promotion of adherence, inhibition of chemotactic migration and superoxide anion release from adherent cells. Kownatzki E; Kapp A; Uhrich S Clin Exp Immunol; 1988 Oct; 74(1):143-8. PubMed ID: 2851397 [TBL] [Abstract][Full Text] [Related]
25. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis. Kew RR; Grimaldi CM; Furie MB; Fleit HB J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856 [TBL] [Abstract][Full Text] [Related]
26. The inhibitory effect of chemotactic factors on erythrophagocytosis by human neutrophils. Musson RA; Becker EL J Immunol; 1976 Aug; 117(2):433-9. PubMed ID: 781130 [TBL] [Abstract][Full Text] [Related]
27. Chemotactic responsiveness and random motility of polymorphonuclear leukocytes from patients with progressive systemic sclerosis. Minta JO; Kovacs EK; Sukenik S; Lee P J Rheumatol; 1985 Dec; 12(6):1125-8. PubMed ID: 4093918 [TBL] [Abstract][Full Text] [Related]
28. N-alpha-p-tosyl-L-lysine chloromethyl ketone (TLCK) suppresses neuritic degeneration caused by different experimental paradigms including in vitro Wallerian degeneration. Ikegami K; Kato S; Koike T Brain Res; 2004 Dec; 1030(1):81-93. PubMed ID: 15567340 [TBL] [Abstract][Full Text] [Related]
29. Neutrophil transepithelial migration in response to the chemoattractant fMLP but not C5a is phospholipase D-dependent and related to the use of CD11b/CD18. Carrigan SO; Pink DB; Stadnyk AW J Leukoc Biol; 2007 Dec; 82(6):1575-84. PubMed ID: 17724165 [TBL] [Abstract][Full Text] [Related]
30. Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor. Rosenbaum JT; Wong K; Perez HD; Raymond W; Howes EL Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1184-91. PubMed ID: 6384121 [TBL] [Abstract][Full Text] [Related]
31. The serine protease inhibitors TLCK and TPCK inhibit the in vitro immortalization of primary human keratinocytes by HPV-18 DNA. Stöppler H; Koval D; Schlegel R Oncogene; 1996 Oct; 13(7):1545-8. PubMed ID: 8875993 [TBL] [Abstract][Full Text] [Related]
32. Aggregation of leukocytes induced by the complement-derived peptides C3a and C5a and by three synthetic formyl-methionyl peptides. Damerau B; Grünefeld E; Vogt W Int Arch Allergy Appl Immunol; 1980; 63(2):159-69. PubMed ID: 7419283 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of human neutrophil migration by aggregated gammaglobulin. Kemp A; Roberts-Thomson P; Brown S Clin Exp Immunol; 1979 May; 36(2):334-41. PubMed ID: 89921 [TBL] [Abstract][Full Text] [Related]
34. Requirement for cell-bound proteases in the mechanism of human neutrophil activation with various stimuli. Smith RJ; Speziale SC; Sam LM; Justen JM; Bowman BJ Inflammation; 1986 Sep; 10(3):257-70. PubMed ID: 3527962 [TBL] [Abstract][Full Text] [Related]
35. Role of purified serum components in polymorphonuclear leukocyte chemotaxis. Czarnetzki BM; Schulz W Int Arch Allergy Appl Immunol; 1980; 61(4):424-30. PubMed ID: 6154015 [TBL] [Abstract][Full Text] [Related]
37. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils: change of receptor affinity and number by L-1-tosylamide-2-phenylethyl chloromethyl ketone (TPCK). Mackin WM; Becker EL Int J Immunopharmacol; 1983; 5(5):365-75. PubMed ID: 6317580 [TBL] [Abstract][Full Text] [Related]
38. Plasma and cell-derived inhibitors of human neutrophil chemotaxis. Goetzl EJ Ann N Y Acad Sci; 1975 Jun; 256():210-21. PubMed ID: 1099960 [No Abstract] [Full Text] [Related]
39. Role of a peptidase in phagocyte chemotaxis. Aswanikumar S; Schiffmann E; Corcoran BA; Wahl SM Proc Natl Acad Sci U S A; 1976 Jul; 73(7):2439-42. PubMed ID: 1065899 [TBL] [Abstract][Full Text] [Related]